<bill session="110" type="h" number="1956" updated="2009-01-08T20:56:40-05:00">
	<status><introduced date="1176955200" datetime="2007-04-19"/></status>

	<introduced date="1176955200" datetime="2007-04-19"/>
	<titles>
		<title type="short" as="introduced">Patient Protection and Innovative Biologic Medicines Act of 2007</title>
		<title type="official" as="introduced">To amend the Public Health Service Act to provide for the approval of similar biological products, and for other purposes.</title>
	</titles>
	<sponsor id="400193"/>
	<cosponsors>
		<cosponsor id="400031" joined="2007-06-28"/>
		<cosponsor id="400177" joined="2007-09-25"/>
		<cosponsor id="400616" joined="2007-05-09"/>
		<cosponsor id="400160" joined="2007-04-19"/>
		<cosponsor id="400092" joined="2007-05-17"/>
		<cosponsor id="412234" joined="2008-09-23"/>
		<cosponsor id="400635" joined="2007-06-25"/>
		<cosponsor id="400271" joined="2007-05-24"/>
		<cosponsor id="400379" joined="2007-05-17"/>
		<cosponsor id="400409" joined="2007-05-01"/>
		<cosponsor id="400396" joined="2007-05-21"/>
		<cosponsor id="412253" joined="2008-01-29"/>
		<cosponsor id="412258" joined="2008-04-29"/>
		<cosponsor id="400311" joined="2008-06-03"/>
		<cosponsor id="400087" joined="2007-05-21"/>
		<cosponsor id="400013" joined="2007-04-19"/>
		<cosponsor id="412240" joined="2008-07-31"/>
		<cosponsor id="412232" joined="2008-06-03"/>
		<cosponsor id="400628" joined="2008-09-23"/>
		<cosponsor id="400009" joined="2008-09-09"/>
		<cosponsor id="400283" joined="2007-07-17"/>
		<cosponsor id="400218" joined="2007-05-17"/>
		<cosponsor id="400179" joined="2008-09-23"/>
		<cosponsor id="400186" joined="2007-07-31"/>
		<cosponsor id="412233" joined="2008-05-15"/>
	</cosponsors>
	<actions>
		<action date="1176955200" datetime="2007-04-19"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action date="1177041600" datetime="2007-04-20"><text>Referred to the Subcommittee on Health.</text></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	4/19/2007--Introduced.<br/>Patient Protection and Innovative Biologic Medicines Act of 2007 - Amends the Public Health Service Act to allow any person to submit an application for approval of a biologics license for a biological product that is claimed to be similar to a qualified biological product (reference product) after 12 years have elapsed since the reference product was approved or licensed.<br/>Allows the Secretary of Health and Human Services to approve such a similar biological product: (1) only if the applicant demonstrates that the product conforms to the applicable final product-class specific guidance and the Secretary concludes the product is safe, pure, and potent; (2) only for indications for which the reference product is approved; and (3) to be effective only after at least 14 years have elapsed since the reference product was approved or licensed.<br/>Prohibits the Secretary from designating a similar biological product as therapeutically equivalent to the reference product.<br/>Prohibits the Secretary from approving a product that is claimed to be similar to or the same as a reference product under any other provision of law.<br/>Authorizes any person to request issuance of product-class specific guidance applicable to a qualified biological product and its class.<br/>Requires the Secretary to establish a Similar Biological Products Advisory Committee.<br/>Sets forth provisions governing the naming of biotechnology-derived therapeutic protein and other biological products. Amends the Federal Food, Drug, and Cosmetic Act to deem a biotechnology-derived therapeutic protein to be misbranded if its labeling fails to meet the requirements of this Act.<br/>
	</summary>
</bill>
